MedPath

Vascular Closure Device in Transcatheter Aortic Valve Replacement

Conditions
Aortic Valve Stenosis
Registration Number
NCT04392492
Lead Sponsor
Karolinska University Hospital
Brief Summary

Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular closure device for femoral artery closure in an unselected consecutive patient cohort undergoing transcatheter aortic valve implantation in a single-center prospective study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Patients undergoing transfemoral TAVI at the Karolinska University Hospital
Exclusion Criteria
  • Patients undergoing TAVI with access other than transfemoral
  • Use of closure device other than MANTA

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of patients with major vascular complications6 week follow up

Major vascular access site complications according to the VARC-2 definitions

Secondary Outcome Measures
NameTimeMethod
Number of patients with minor vascular complications6 week follow up

Minor vascular access site complications according to the VARC-2 definitions

Number of patients with vascular closure device failure6 week follow up

Percutaneous vascular closure device failure according to the VARC-2 definitions

Number of patients with life-threatening, disabling or major bleeding6 week follow up

Life-threatening, disabling or major bleeding complications according to the BARC definitions

Trial Locations

Locations (1)

Department of Cardiology, Karolinska University Hospital

🇸🇪

Stockholm, Sweden

Department of Cardiology, Karolinska University Hospital
🇸🇪Stockholm, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.